preprint · Research Square (Research Square)
Abstract Thromboembolism is the cause of significant mortality and morbidity in cancer patients. While the link between cancer and venous thrombosis is well known, the recognition of arterial thrombosis as a serious complication of cancer and chemotherapeutic agents is a recent development. One of the chemotherapy agents frequently linked to acute vascular events is cisplatin. We discuss the rare case of cisplatin-related brachial arterial thrombosis in a 50-year-old man from Ethiopia who was undergoing treatment for cholangiocarcinoma with cisplatin and gemcitabine chemotherapy. Although rare, cisplatin-related arterial thrombosis demands careful monitoring, a high index of suspicion, and prompt management to prevent serious morbidity and mortality.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21203/rs.3.rs-3937419/v1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.